200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 3721-26-4

3721-26-4

3721-26-4 | (1R,2S)-2-phenylcyclopropan-1-amine

CAS No: 3721-26-4 Catalog No: AG0035Y8 MDL No:MFCD00865363

Product Description

Catalog Number:
AG0035Y8
Chemical Name:
(1R,2S)-2-phenylcyclopropan-1-amine
CAS Number:
3721-26-4
Molecular Formula:
C9H11N
Molecular Weight:
133.1903
MDL Number:
MFCD00865363
IUPAC Name:
(1R,2S)-2-phenylcyclopropan-1-amine
InChI:
InChI=1S/C9H11N/c10-9-6-8(9)7-4-2-1-3-5-7/h1-5,8-9H,6,10H2/t8-,9+/m0/s1
InChI Key:
AELCINSCMGFISI-DTWKUNHWSA-N
SMILES:
N[C@@H]1C[C@H]1c1ccccc1
EC Number:
205-841-9

Properties

Complexity:
116  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0
Exact Mass:
133.089g/mol
Formal Charge:
0
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
133.194g/mol
Monoisotopic Mass:
133.089g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
26A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.5  

Literature

Title Journal
In vitro toxicological evaluation of NCS-382, a high-affinity antagonist of γ-hydroxybutyrate (GHB) binding. Toxicology in vitro : an international journal published in association with BIBRA 20170401
Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class. Toxicology letters 20160122
Investigations on the metabolic stability of cytosolic phospholipase A2α inhibitors with 1-indolylpropan-2-one structure. Chemico-biological interactions 20131125
Interactions of sesquiterpenes zederone and germacrone with the human cytochrome P450 system. Toxicology in vitro : an international journal published in association with BIBRA 20130901
Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions. Journal of applied toxicology : JAT 20130201
In silico and intuitive predictions of CYP46A1 inhibition by marketed drugs with subsequent enzyme crystallization in complex with fluvoxamine. Molecular pharmacology 20121101
Risperidone attenuates the increase of extracellular nitric oxide and glutamate levels in serotonin syndrome animal models. Neuroscience letters 20121018
Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes. Drug metabolism and disposition: the biological fate of chemicals 20120901
Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma. Human pathology 20120801
Tranylcypromine and bupropion combination therapy in treatment-resistant major depression: a report of 2 cases. Journal of clinical psychopharmacology 20120801
Novel colorimetric assay of LSD1 activity using gold nanoparticles. The Analyst 20120607
Pioglitazone treatment increases COX-2-derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function. British journal of pharmacology 20120601
On the presence of serotonin in mammalian cardiomyocytes. Molecular and cellular biochemistry 20120601
[Effect of monoamine oxidase inhibitor on the differentiation of malignant glioma cell]. Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 20120601
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry 20120524
Anxiety-like behavior and cognitive flexibility in adult rats perinatally exposed to increased serotonin concentrations. Behavioural brain research 20120421
The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. Cancer cell 20120417
Effects of amitriptyline, fluoxetine, tranylcypromine and venlafaxine on rat vascular smooth muscle in vitro--the role of the endothelium. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20120401
FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure. Nature communications 20120327
Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms. Journal of chemical information and modeling 20120326
Oligoamine analogues in combination with 2-difluoromethylornithine synergistically induce re-expression of aberrantly silenced tumour-suppressor genes. The Biochemical journal 20120315
Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nature medicine 20120311
Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [(11)C]-harmine positron emission tomography study. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20120301
Noradrenaline increases neural precursor cells derived from adult rat dentate gyrus through β2 receptor. Progress in neuro-psychopharmacology & biological psychiatry 20120110
The effects of chronic administration of tranylcypromine and rimonabant on behaviour and protein expression in brain regions of the rat. Pharmacology, biochemistry, and behavior 20120101
GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder. Frontiers in molecular neuroscience 20120101
Antidepressant treatment for acute bipolar depression: an update. Depression research and treatment 20120101
Neuroimmune endocrine effects of antidepressants. Neuropsychiatric disease and treatment 20120101
Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial. BMJ open 20120101
Genome-wide DNA methylation scan in major depressive disorder. PloS one 20120101
Psychiatric patient and anaesthesia. Indian journal of anaesthesia 20120101
Effects of stimulation and blockade of d(2) receptor on depression-like behavior in ovariectomized female rats. ISRN pharmacology 20120101
Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good. Frontiers in psychology 20120101
Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient preference and adherence 20120101
Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Molecular carcinogenesis 20111201
The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression. Genes, chromosomes & cancer 20111201
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology 20111201
Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. The Journal of clinical psychiatry 20111201
Neurotrophins role in depression neurobiology: a review of basic and clinical evidence. Current neuropharmacology 20111201
Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors. Human pathology 20111101
Lights and shadows on monoamine oxidase inhibition in neuroprotective pharmacological therapies. Current topics in medicinal chemistry 20111101
Effects of CYP inhibitors on precocene I metabolism and toxicity in rat liver slices. Chemico-biological interactions 20110905
Luciferin IPA-based higher throughput human hepatocyte screening assays for CYP3A4 inhibition and induction. Journal of biomolecular screening 20110901
A consensus statement for safety monitoring guidelines of treatments for major depressive disorder. The Australian and New Zealand journal of psychiatry 20110901
Evaluation of the effects of Mitragyna speciosa alkaloid extract on cytochrome P450 enzymes using a high throughput assay. Molecules (Basel, Switzerland) 20110829
Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors. Neuro-oncology 20110801
The effects of the perinatal treatment with 5-hydroxytryptophan or tranylcypromine on the peripheral and central serotonin homeostasis in adult rats. Neurochemistry international 20110801
Activation of HIV transcription by the viral Tat protein requires a demethylation step mediated by lysine-specific demethylase 1 (LSD1/KDM1). PLoS pathogens 20110801
Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo. British journal of pharmacology 20110701
Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors. Bioorganic & medicinal chemistry 20110615
Thyroid hormone suppression of β-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events. Molecular and cellular endocrinology 20110606
Serotonergic mechanism underlying tranylcypromine enhancement of nicotine self-administration. Synapse (New York, N.Y.) 20110601
Fluoxetine treatment induces EAAT2 expression in rat brain. Journal of neural transmission (Vienna, Austria : 1996) 20110601
Fine-tuning the selectivity of aldosterone synthase inhibitors: structure-activity and structure-selectivity insights from studies of heteroaryl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one derivatives. Journal of medicinal chemistry 20110414
A systematic experimental neuropsychological investigation of the functional integrity of working memory circuits in major depression. European archives of psychiatry and clinical neuroscience 20110401
Identification and induction of cytochrome P450s involved in the metabolism of flavone-8-acetic acid in mice. Drug metabolism letters 20110401
Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials. The Journal of clinical psychiatry 20110401
Simple, direct, and informative method for the assessment of CYP2C19 enzyme inactivation kinetics. Drug metabolism and disposition: the biological fate of chemicals 20110301
Endothelin-1 attenuates increases in hydraulic conductivity due to platelet-activating factor via prostacyclin release. Journal of applied physiology (Bethesda, Md. : 1985) 20110301
Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. European journal of drug metabolism and pharmacokinetics 20110301
MAO-inhibitors in Parkinson's Disease. Experimental neurobiology 20110301
Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors. Journal of clinical psychopharmacology 20110201
Synthesis, antidepressant and antifungal evaluation of novel 2-chloro-8-methylquinoline amine derivatives. European journal of medicinal chemistry 20110201
New drug-like hydroxyphenylnaphthol steroidomimetics as potent and selective 17β-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of estrogen-dependent diseases. Journal of medicinal chemistry 20110127
Identification of human liver cytochrome P450 enzymes involved in the metabolism of SCH 530348 (Vorapaxar), a potent oral thrombin protease-activated receptor 1 antagonist. Drug metabolism and disposition: the biological fate of chemicals 20110101
Role of arachidonic acid-derived metabolites in the control of pulmonary arterial pressure and hypoxic pulmonary vasoconstriction in rats. British journal of anaesthesia 20110101
Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light. Frontiers in behavioral neuroscience 20110101
Identification of candidate small-molecule therapeutics to cancer by gene-signature perturbation in connectivity mapping. PloS one 20110101
Behavioral impairment and oxidative damage induced by chronic application of nonylphenol. International journal of molecular sciences 20110101
Alterations in striatal oxidative stress level produced by pharmacological manipulation of dopamine as shown by a novel synthetic marker molecule. Neuropharmacology 20110101
The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition. Neuropharmacology 20110101
Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain. Journal of pain research 20110101
Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review. Journal of pharmacy & bioallied sciences 20110101
Therapeutic strategies to enhance the anticancer efficacy of histone deacetylase inhibitors. Journal of biomedicine & biotechnology 20110101
Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression. Frontiers in psychology 20110101
Serotonin-mediated tuning of human helper T cell responsiveness to the chemokine CXCL12. PloS one 20110101
Chemical biology of lysine demethylases. Current chemical genomics 20110101
Methods for Activity Analysis of the Proteins that Regulate Histone Methylation. Current chemical genomics 20110101
Epigenetics in breast cancer: what's new? Breast cancer research : BCR 20110101
Psychiatric diseases: Need for an increased awareness among the anesthesiologists. Journal of anaesthesiology, clinical pharmacology 20110101
Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons. ISRN neurology 20110101
α7 and β2 nicotinic receptors control monoamine-mediated locomotor response. Neuroreport 20101208
On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B. Pharmacological research 20101201
Cytochrome P450-mediated hepatic metabolism of new fluorescent substrates in cats and dogs. Journal of veterinary pharmacology and therapeutics 20101201
Potentiation of ligand binding through cooperative effects in monoamine oxidase B. The Journal of biological chemistry 20101119
Serotonin syndrome with severe hyperthermia after ingestion of tranylcypromine combined with serotonin reuptake inhibitors and tyramine-rich food in a case of suicide. Pharmacopsychiatry 20101101
Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain. The Journal of biological chemistry 20101008
Mirtazapine abolishes hyperthermia in an animal model of serotonin syndrome. Neuroscience letters 20101004
[Tranylcypromine for chronic therapy-resistant agoraphobia with panic disorder and recurrent depressive disorder]. Psychiatrische Praxis 20101001
Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1 . Biochemistry 20100803
limited potentiation of blood pressure in response to oral tyramine by the anti-Parkinson brain selective multifunctional monoamine oxidase-AB inhibitor, M30. Neurotoxicity research 20100801
Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome. Journal of clinical psychopharmacology 20100801
Role of alpha-adrenoceptors and prostacyclin in the enhanced adrenergic reactivity of goat cerebral arteries after ischemia-reperfusion. Brain research 20100730
Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2. Journal of the American Chemical Society 20100519
In vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine. Cancer chemotherapy and pharmacology 20100401
Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors. Journal of the American Chemical Society 20100310
Age influences the effects of nicotine and monoamine oxidase inhibition on mood-related behaviors in rats. Psychopharmacology 20100301
Double-blind comparison of 30 and 60 mg tranylcypromine daily in patients with panic disorder comorbid with social anxiety disorder. Psychiatry research 20100227
Transport of phenylethylamine at intestinal epithelial (Caco-2) cells: mechanism and substrate specificity. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20100201
Bioactivation of lamotrigine in vivo in rat and in vitro in human liver microsomes, hepatocytes, and epidermal keratinocytes: characterization of thioether conjugates by liquid chromatography/mass spectrometry and high field nuclear magnetic resonance spectroscopy. Chemical research in toxicology 20100101
Degeneration of dopaminergic neurons induced by thrombin injection in the substantia nigra of the rat is enhanced by dexamethasone: role of monoamine oxidase enzyme. Neurotoxicology 20100101
Gas chromatography-mass spectrometry detection of a norfluoxetine artifact in hydrolyzed urine samples may falsely indicate tranylcypromine ingestion. Journal of analytical toxicology 20100101
Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease. Molecular neurodegeneration 20100101
The role of rasagiline in the treatment of Parkinson's disease. Clinical interventions in aging 20100101
Effects of CYP2C9*3 and CYP2C9*13 on Diclofenac Metabolism and Inhibition-based Drug-Drug Interactions. Drug metabolism and pharmacokinetics 20100101
An overview of curcumin in neurological disorders. Indian journal of pharmaceutical sciences 20100101
Getting the balance right: Established and emerging therapies for major depressive disorders. Neuropsychiatric disease and treatment 20100101
Epigenetic mechanisms regulate stem cell expressed genes Pou5f1 and Gfra1 in a male germ cell line. PloS one 20100101
Mating alters gene expression patterns in Drosophila melanogaster male heads. BMC genomics 20100101
Estrogens of multiple classes and their role in mental health disease mechanisms. International journal of women's health 20100101
A new strategy for antidepressant prescription. Frontiers in neuroscience 20100101
Delirium, thrombocytopenia, insomnia, and mild liver damage associated with MAOI withdrawal. European journal of clinical pharmacology 20091201
TCP-FA4: a derivative of tranylcypromine showing improved blood-brain permeability. Biochemical pharmacology 20091201
Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem cells (Dayton, Ohio) 20091201
Ovariectomy increases the formation of prostanoids and modulates their role in acetylcholine-induced relaxation and nitric oxide release in the rat aorta. Cardiovascular research 20091101
Ti: myths about monoamine oxidase inhibitors perpetuated. The Australian and New Zealand journal of psychiatry 20091101
Human and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands. The Biochemical journal 20091023
Accuracy of Veterans Affairs databases for diagnoses of chronic diseases. Preventing chronic disease 20091001
Long-term portal hypertension increases the vasodilator response to acetylcholine in rat aorta: role of prostaglandin I2. Clinical science (London, England : 1979) 20090907
Structure, function, regulation and polymorphism of human cytochrome P450 2A6. Current drug metabolism 20090901
Chromatin regulation in drug addiction and depression. Dialogues in clinical neuroscience 20090901
The neurotrophic and neuroprotective effects of psychotropic agents. Dialogues in clinical neuroscience 20090901
Trans-2-phenylcyclopropylamine induces nerve cells apoptosis in zebrafish mediated by depression of LSD1 activity. Brain research bulletin 20090828
Recent advances in the development of polyamine analogues as antitumor agents. Journal of medicinal chemistry 20090813
Commentary on STAR*D: a summary and UK perspective. Journal of psychopharmacology (Oxford, England) 20090801
C-reactive protein impairs coronary arteriolar dilation to prostacyclin synthase activation: role of peroxynitrite. Journal of molecular and cellular cardiology 20090801
STAR*D: revising conventional wisdom. CNS drugs 20090801
A novel mammalian flavin-dependent histone demethylase. The Journal of biological chemistry 20090626
Functional expression, inhibition and induction of CYP enzymes in HepaRG cells. Toxicology in vitro : an international journal published in association with BIBRA 20090601
Tranylcypromine dependence and withdrawal. The Australian and New Zealand journal of psychiatry 20090601
Running wheel activity is sensitive to acute treatment with selective inhibitors for either serotonin or norepinephrine reuptake. Psychopharmacology 20090501
NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds. Bioorganic & medicinal chemistry 20090501
[Irreversible, non-selective monoamine oxidase inhibitors]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20090416
The habenular nuclei: a conserved asymmetric relay station in the vertebrate brain. Philosophical transactions of the Royal Society of London. Series B, Biological sciences 20090412
Monoaminergic regulation of Sonic hedgehog signaling cascade expression in the adult rat hippocampus. Neuroscience letters 20090410
Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action. Journal of medicinal chemistry 20090409
Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environmental health perspectives 20090401
Antidepressants reveal differential effect against 1-methyl-4-phenylpyridinium toxicity in differentiated PC12 cells. European journal of pharmacology 20090214
Inhibition of monoamine oxidases desensitizes 5-HT1A autoreceptors and allows nicotine to induce a neurochemical and behavioral sensitization. The Journal of neuroscience : the official journal of the Society for Neuroscience 20090128
Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia. Schizophrenia bulletin 20090101
Brain-derived neurotrophic factor: role in depression and suicide. Neuropsychiatric disease and treatment 20090101
Hypertensive crisis and cheese. Indian journal of psychiatry 20090101
Drugs associated with more suicidal ideations are also associated with more suicide attempts. PloS one 20090101
Role of a non-hormonal oral anti-fibrinolytic hemostatic agent (tranexamic acid) for management of patients with dysfunctional uterine bleeding. Clinical and experimental obstetrics & gynecology 20090101
Social phobia following maprotiline: the first case report. Cases journal 20090101
Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality. Cardiology research and practice 20090101
In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1H-quinolin-2-one derivatives. Journal of medicinal chemistry 20081225
Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice. Psychopharmacology 20081201
Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology 20081201
The 5-hydroxytryptamine2A receptor antagonist R-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential-reinforcement-of-low-rate 72-s behavior in the rat. The Journal of pharmacology and experimental therapeutics 20081201
Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents. Journal of neural transmission (Vienna, Austria : 1996) 20081201
Electroconvulsive therapy and monoamine oxidase inhibitors. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20081201
Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues in clinical neuroscience 20081201
Pharmacology and therapeutic potential of sigma(1) receptor ligands. Current neuropharmacology 20081201
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry 20081113
Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers. Drug metabolism and disposition: the biological fate of chemicals 20081101
Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-thienyl)pyrazoline derivatives. Archiv der Pharmazie 20081101
NF-Y substitutes H2A-H2B on active cell-cycle promoters: recruitment of CoREST-KDM1 and fine-tuning of H3 methylations. Nucleic acids research 20081101
Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression. Pharmacopsychiatry 20081101
Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approach. Journal of medicinal chemistry 20081009
Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems. Canadian journal of physiology and pharmacology 20081001
Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis. The Journal of clinical psychiatry 20081001
Elevation of inducible nitric oxide synthase and cyclooxygenase-2 expression in the mouse brain after chronic nonylphenol exposure. International journal of molecular sciences 20081001
Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout models. Current neuropharmacology 20080901
Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on potency and selectivity. Journal of medicinal chemistry 20080828
Antidepressant treatments regulate matrix metalloproteinases-2 and -9 (MMP-2/MMP-9) and tissue inhibitors of the metalloproteinases (TIMPS 1-4) in the adult rat hippocampus. Synapse (New York, N.Y.) 20080801
Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin. British journal of pharmacology 20080701
Complexes of the copper-containing amine oxidase from Arthrobacter globiformis with the inhibitors benzylhydrazine and tranylcypromine. Acta crystallographica. Section F, Structural biology and crystallization communications 20080701
Repeated unpredictable stress and antidepressants differentially regulate expression of the bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080601
Chronic ouabain treatment increases the contribution of nitric oxide to endothelium-dependent relaxation. Journal of physiology and biochemistry 20080601
Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20080516
Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B. Bioorganic & medicinal chemistry letters 20080515
Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression. Psychopharmacology 20080401
Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition. Neurochemical research 20080301
Withdrawal from high-dose tranylcypromine. Clinical toxicology (Philadelphia, Pa.) 20080301
Orchidectomy increases the formation of prostanoids and modulates their role in the acetylcholine-induced relaxation in the rat aorta. Cardiovascular research 20080201
Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A. Biochemical and biophysical research communications 20080201
Pharmacological management of panic disorder. Neuropsychiatric disease and treatment 20080201
Rasagiline in treatment of Parkinson's disease. Neuropsychiatric disease and treatment 20080201
Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene. PloS one 20080101
Diverse antidepressants increase CDP-diacylglycerol production and phosphatidylinositide resynthesis in depression-relevant regions of the rat brain. BMC neuroscience 20080101
[The treatment of psychotic depression in patients insufficiently responsive to conventional medication and electroconvulsive therapy; what are the options?]. Tijdschrift voor psychiatrie 20080101
Antidepressant drugs modulate growth factors in cultured cells. BMC pharmacology 20080101
ZNF198 stabilizes the LSD1-CoREST-HDAC1 complex on chromatin through its MYM-type zinc fingers. PloS one 20080101
Defeating cancer with antidepressants. Ecancermedicalscience 20080101
Rivastigmine-induced dystonia. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20071201
The guinea pig forced swim test as a new behavioral despair model to characterize potential antidepressants. Psychopharmacology 20071101
Not all monoamine oxidase inhibitors are created equal. Journal of the American Geriatrics Society 20071101
Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice. Neuropharmacology 20071001
Pharmacological causes of hyperprolactinemia. Therapeutics and clinical risk management 20071001
New antidepressants or more of the same? Neuropsychiatric disease and treatment 20071001
Transdermal selegiline for the treatment of major depressive disorder. Neuropsychiatric disease and treatment 20071001
Involvement of alpha1-adrenergic receptors in tranylcypromine enhancement of nicotine self-administration in rat. Psychopharmacology 20070901
In vitro assessment of cytochrome P450 inhibition: strategies for increasing LC/MS-based assay throughput using a one-point IC(50) method and multiplexing high-performance liquid chromatography. Journal of pharmaceutical sciences 20070901
Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders? Journal of psychiatry & neuroscience : JPN 20070901
Reduced evoked fos expression in activity-related brain regions in animal models of behavioral depression. Progress in neuro-psychopharmacology & biological psychiatry 20070815
Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. European journal of pharmacology 20070813
Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway. Cardiovascular research 20070715
Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine. Biochemistry 20070710
Effect on [11C]DASB binding after tranylcypromine-induced increase in serotonin concentration: positron emission tomography studies in monkeys and rats. Synapse (New York, N.Y.) 20070601
Biological targets for isatin and its analogues: Implications for therapy. Biologics : targets & therapy 20070601
Tranylcypromine enhancement of nicotine self-administration. Neuropharmacology 20070501
Under-recruitment of patients for clinical trials: an illustrative example of a failed study. Acta psychiatrica Scandinavica 20070501
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta psychiatrica Scandinavica 20070501
trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1. Biochemistry 20070410
STAR*D level IV methodology. The American journal of psychiatry 20070401
Acute chorea and hyperthermia after concurrent use of modafinil and tranylcypromine. The American journal of psychiatry 20070401
Motor cortex excitability after vagus nerve stimulation in major depression. Journal of clinical psychopharmacology 20070401
Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression. Journal of clinical psychopharmacology 20070401
Running exercise- and antidepressant-induced increases in growth and survival-associated signaling molecules are IGF-dependent. Growth factors (Chur, Switzerland) 20070401
Treatment with low doses of tranylcypromine resulted in a disappointing remission rate. The American journal of psychiatry 20070301
Venlafaxine extended release (XR) in the treatment of panic disorder. Therapeutics and clinical risk management 20070301
STAR*D: what have we learned? The American journal of psychiatry 20070201
Venlafaxine in the treatment of panic disorder. Neuropsychiatric disease and treatment 20070201
Honokiol up-regulates prostacyclin synthease protein expression and inhibits endothelial cell apoptosis. European journal of pharmacology 20070105
CYP3A4 mediated in vitro metabolism of vinflunine in human liver microsomes. Acta pharmacologica Sinica 20070101
Perceived efficacy of herbal remedies by users accessing primary healthcare in Trinidad. BMC complementary and alternative medicine 20070101
Hydrazine and amphetamine binding to amine oxidases: old drugs with new prospects. Journal of neural transmission (Vienna, Austria : 1996) 20070101
[Experimental investigations of the analgesic activity of fentanyl and the non-opiodal agents -clonidine and isradipine, and protease inhibitors]. Anesteziologiia i reanimatologiia 20070101
A possible role for the endocannabinoid system in the neurobiology of depression. Clinical practice and epidemiology in mental health : CP & EMH 20070101
[Optimization of anesthetic maintenance of a facial dermabrasion operation]. Anesteziologiia i reanimatologiia 20070101
New findings from the Bipolar Collaborative Network: clinical implications for therapeutics. Current psychiatry reports 20061201
Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L-DOPA in the rat. British journal of pharmacology 20061101
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice. PLoS medicine 20061101
Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression. Journal of clinical psychopharmacology 20061001
Keeping our eyes on STAR*D. The American journal of psychiatry 20060901
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. The American journal of psychiatry 20060901
Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in mice. The European journal of neuroscience 20060901
Biphasic change in BDNF gene expression following antidepressant drug treatment explained by differential transcript regulation. Brain research 20060823
Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060801
Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg/24 h in healthy subjects. Journal of clinical pharmacology 20060801
Tranylcypromine: new perspectives on an 'old' drug. European archives of psychiatry and clinical neuroscience 20060801
Characterization of hepatic drug-metabolizing activities of Bama miniature pigs (Sus scrofa domestica): comparison with human enzyme analogs. Comparative medicine 20060801
Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells. European journal of pharmacology 20060710
Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (R)-[11C]rolipram in rat brain, lung and heart. Life sciences 20060620
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chemistry & biology 20060601
Depression and sleep: pathophysiology and treatment. Dialogues in clinical neuroscience 20060601
[Life-threatening serotonin syndrome following a single dose of a serotonin reuptake inhibitor during maintenance therapy with a monoamine oxidase inhibitor]. Nederlands tijdschrift voor geneeskunde 20060513
The decrease of NAD(P)H has a prominent role in dopamine toxicity. Biochimica et biophysica acta 20060501
Leading the way: advances in the diagnosis, treatment, and management of neuropsychiatric illnesses. CNS spectrums 20060501
Transdermal selegiline: the new generation of monoamine oxidase inhibitors. CNS spectrums 20060501
An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid. British journal of clinical pharmacology 20060501
Use of antidepressant medications in relation to the incidence of breast cancer. British journal of cancer 20060410
Enhancement of drug affinity for cell membranes by conjugation with lipoamino acids II. Experimental and computational evidence using biomembrane models. International journal of pharmaceutics 20060309
Effects of monoamine oxidase inhibitors on cocaine discrimination in rats. Behavioural pharmacology 20060301
Metabolism of nicotine in rat lung microvascular endothelial cells. The Journal of pharmacy and pharmacology 20060301
Combination rapid transcranial magnetic stimulation in treatment refractory depression. Neuropsychiatric disease and treatment 20060301
Nitric oxide synthesis is required for exercise-induced increases in hippocampal BDNF and phosphatidylinositol 3' kinase expression. Brain research bulletin 20060115
[Hemostatic provision of surgical treatment of juvenile angiofibromas of the skull base in children]. Vestnik otorinolaringologii 20060101
[A case of tianeptine abuse]. Turk psikiyatri dergisi = Turkish journal of psychiatry 20060101
Isatin interaction with glyceraldehyde-3-phosphate dehydrogenase, a putative target of neuroprotective drugs: partial agonism with deprenyl. Journal of neural transmission. Supplementum 20060101
Neurogenesis and the effect of antidepressants. Drug target insights 20060101
Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review. European archives of psychiatry and clinical neuroscience 20051201
Combination/augmentation strategies for improving the treatment of depression. Neuropsychiatric disease and treatment 20051201
Enhancement of drug affinity for cell membranes by conjugation with lipoamino acids. I. Synthesis and biological evaluation of lipophilic conjugates of tranylcypromine. European journal of medicinal chemistry 20051101
Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats. Psychopharmacology 20051101
[Metabolic kinetics of MN9202 in Beagle dog liver microsomes]. Yao xue xue bao = Acta pharmaceutica Sinica 20051101
The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats. British journal of pharmacology 20051001
Cyp2a6 is a principal enzyme involved in hydroxylation of 1,7-dimethylxanthine, a main caffeine metabolite, in humans. Drug metabolism and disposition: the biological fate of chemicals 20050901
Antidepressants differentially affect expression of complexin I and II RNA in rat hippocampus. Psychopharmacology 20050901
The pharmacological management of depression. Dialogues in clinical neuroscience 20050901
The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants. Dialogues in clinical neuroscience 20050901
An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environmental health perspectives 20050801
Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats. Hypertension (Dallas, Tex. : 1979) 20050701
The serotonin syndrome. The New England journal of medicine 20050609
Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors. Journal of medicinal chemistry 20050602
Microplates with integrated oxygen sensors for kinetic cell respiration measurement and cytotoxicity testing in primary and secondary cell lines. Assay and drug development technologies 20050601
Do antihypertensives make tranylcypromine safer? Three case reports. The Journal of clinical psychiatry 20050501
Exercise activates the phosphatidylinositol 3-kinase pathway. Brain research. Molecular brain research 20050427
Facilitation of spontaneous glutamate release by antidepressant drugs in rat locus coeruleus. Neuroscience letters 20050210
Receptor rigidity and ligand mobility in trypsin-ligand complexes. Proteins 20050201
Potential of [11C]DASB for measuring endogenous serotonin with PET: binding studies. Nuclear medicine and biology 20050201
[Experimental studies of the analgesic activity of transamine and its combination with phentanyl]. Anesteziologiia i reanimatologiia 20050101
Bipolar depression: issues in diagnosis and treatment. Harvard review of psychiatry 20050101
Antidepressant apathy syndrome. Perspectives in psychiatric care 20050101
Endogenous prostacyclin increases neuronal nitric oxide release in mesenteric artery from spontaneously hypertensive rats. European journal of pharmacology 20041215
Is dopamine a limiting factor of the antidepressant-like effect in the mouse forced swimming test? Progress in neuro-psychopharmacology & biological psychiatry 20041201
Fluorinated phenylcyclopropylamines. 2. Effects of aromatic ring substitution and of absolute configuration on inhibition of microbial tyramine oxidase. Journal of medicinal chemistry 20041118
Chronic antidepressant medication attenuates dexamethasone-induced neuronal death and sublethal neuronal damage in the hippocampus and striatum. Brain research 20041112
Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients. The Journal of clinical psychiatry 20041101
Medical implications from the crystal structure of a copper-containing amine oxidase complexed with the antidepressant drug tranylcypromine. FEBS letters 20041022
Effect of antidepressants on GABA(B) receptor function and subunit expression in rat hippocampus. Biochemical pharmacology 20041015
Liquid chromatographic and tandem mass spectrometric assay for evaluation of in vivo inhibition of rat brain monoamine oxidases (MAO) A and B following a single dose of MAO inhibitors: application of biomarkers in drug discovery. Analytical biochemistry 20041001
Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice. European journal of pharmacology 20040919
Concomitant use of modafinil and tranylcypromine in a patient with narcolepsy: a case report. Sleep medicine 20040901
Monoamine oxidase inhibitors, their structural analogues, and neuroprotection. Indian journal of experimental biology 20040901
Drug-drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338. European journal of pharmacology 20040823
Behavioral alterations in response to fear-provoking stimuli and tranylcypromine induced by perinatal exposure to bisphenol A and nonylphenol in male rats. Environmental health perspectives 20040801
Endothelin-1 decreases postcapillary fluid efflux via prostacyclin release. Surgery 20040801
Monoamine oxidase inhibitors and subarachnoid hemorrhage. Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040801
Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine. Progress in neuro-psychopharmacology & biological psychiatry 20040701
The biogenic trace amine tyramine induces a pronounced hydroxyl radical production via a monoamine oxidase dependent mechanism: an in vivo microdialysis study in mouse striatum. Brain research 20040625
Evaluation of the effect of chronic antidepressant treatment on neurokinin-1 receptor expression in the rat brain. Neuropharmacology 20040601
Validated assays for human cytochrome P450 activities. Drug metabolism and disposition: the biological fate of chemicals 20040601
Involvement of ceramide in the mechanism of Cr(VI)-induced apoptosis of CHO cells. Free radical research 20040601
Fluorinated phenylcyclopropylamines. Part 3: Inhibition of monoamine oxidase A and B. Bioorganic & medicinal chemistry 20040515
Zinc treatment induces cortical brain-derived neurotrophic factor gene expression. European journal of pharmacology 20040510
Purification and characterization of recombinant human prostacyclin synthase. Journal of biochemistry 20040401
Fluorinated phenylcyclopropylamines. 1. Synthesis and effect of fluorine substitution at the cyclopropane ring on inhibition of microbial tyramine oxidase. Journal of medicinal chemistry 20040325
Role of cyclooxygenase in ventricular effects of adrenomedullin: is adrenomedullin a double-edged sword in sepsis? American journal of physiology. Heart and circulatory physiology 20040301
Current perspectives in the management of treatment-resistant depression. Dialogues in clinical neuroscience 20040301
Exercise, antidepressant treatment, and BDNF mRNA expression in the aging brain. Pharmacology, biochemistry, and behavior 20040201
Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6. Cellular and molecular neurobiology 20040201
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Controlled clinical trials 20040201
Utility of microtiter plate assays for human cytochrome P450 inhibition studies in drug discovery: application of simple method for detecting quasi-irreversible and irreversible inhibitors. Drug metabolism and pharmacokinetics 20040201
Differential regulation of synaptic vesicle proteins by antidepressant drugs. The pharmacogenomics journal 20040101
Efficacy of quality criteria to identify potentially harmful information: a cross-sectional survey of complementary and alternative medicine web sites. Journal of medical Internet research 20040101
Genetics of tobacco use. Tobacco induced diseases 20040101
Chip-based P450 drug metabolism coupled to electrospray ionization-mass spectrometry detection. Analytical chemistry 20031201
'Open access' generic method for continuous determination of major human CYP450 probe substrates/metabolites and its application in drug metabolism studies. Xenobiotica; the fate of foreign compounds in biological systems 20031201
Treatment of seasonal affective disorders. Dialogues in clinical neuroscience 20031201
[Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases]. Nederlands tijdschrift voor geneeskunde 20031004
[Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression]. Nederlands tijdschrift voor geneeskunde 20031004
Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biological psychiatry 20031001
Successful suppression of cataplectic attacks with tramadol. Neurology 20030923
Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 20030901
Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors. Pharmacology, biochemistry, and behavior 20030901
Fatal interaction between tranylcypromine and imipramine. European psychiatry : the journal of the Association of European Psychiatrists 20030801
Cytochrome P450 inhibition using recombinant proteins and mass spectrometry/multiple reaction monitoring technology in a cassette incubation. Drug metabolism and disposition: the biological fate of chemicals 20030701
Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 20030601
Induction of hepatic heme oxygenase-1 by diclofenac in rodents: role of oxidative stress and cytochrome P-450 activity. Journal of hepatology 20030601
In vitro inhibition of human small intestinal and liver microsomal astemizole O-demethylation: different contribution of CYP2J2 in the small intestine and liver. Xenobiotica; the fate of foreign compounds in biological systems 20030601
Scaling down. The American journal of psychiatry 20030501
Inhibition of six copper-containing amine oxidases by the antidepressant drug tranylcypromine. Biochimica et biophysica acta 20030411
Nitric oxide and prostacyclin play a role in the regulation of microvascular protein and hydraulic permeability in cat skeletal muscle. Microcirculation (New York, N.Y. : 1994) 20030401
Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant. Pharmacology, biochemistry, and behavior 20030401
Regulation of GAP-43 expression by chronic desipramine treatment in rat cultured hippocampal cells. Biological psychiatry 20030315
Metabolism and metabolic inhibition of cilnidipine in human liver microsomes. Acta pharmacologica Sinica 20030301
[11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats. Synapse (New York, N.Y.) 20030201
Effects of stress and tranylcypromine on amphetamine-induced locomotor activity and GABA(B) receptor function in rat brain. Life sciences 20030117
Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate. Rapid communications in mass spectrometry : RCM 20030101
Isomer-specific bioactivation and toxicity of dichlorophenyl methylsulphone in rat olfactory mucosa. Toxicologic pathology 20030101
Does depression influence symptom severity in irritable bowel syndrome? Case study of a patient with irritable bowel syndrome and bipolar disorder. Psychosomatic medicine 20030101
Antidepressant drug treatment induces Arc gene expression in the rat brain. Neuroscience 20030101
Effects of tranylcypromine on the sleep of patients with anergic bipolar depression. Psychopharmacology bulletin 20030101
[Does addiction to antidepressants exist? About a case of one addiction to tianeptine]. L'Encephale 20030101
Endogenous nitric oxide reduces microvascular permeability and tissue oedema during exercise in cat skeletal muscle. Journal of vascular research 20030101
Expression profile and up-regulation of PRAX-1 mRNA by antidepressant treatment in the rat brain. Molecular pharmacology 20021201
Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours. Neuropharmacology 20021201
Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits. Neuropharmacology 20021101
Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. Life sciences 20020816
Probing the catalytic mechanism of Escherichia coli amine oxidase using mutational variants and a reversible inhibitor as a substrate analogue. The Biochemical journal 20020801
Successful treatment of a complicated case of neuroleptic malignant syndrome. Intensive care medicine 20020701
The N-demethylation of the doxepin isomers is mainly catalyzed by the polymorphic CYP2C19. Pharmaceutical research 20020701
Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice. Journal of psychiatry & neuroscience : JPN 20020501
Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment. The Journal of pharmacology and experimental therapeutics 20020301
Successful treatment of recurrent brief depression with reboxetine -- a single case analysis. Pharmacopsychiatry 20020301
Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO). Journal of neural transmission (Vienna, Austria : 1996) 20020301
Endothelin-1 reduces microvascular fluid permeability through secondary release of prostacyclin in cat Skeletal muscle. Microvascular research 20020101
Effects of psychotropic drugs on seizure threshold. Drug safety 20020101
Modulation of prostacyclin and thromboxane secretion by cytotrophoblasts from normal and pre-eclamptic human pregnancies. Placenta 20020101
[Protease inhibitors as an anesthetic component in ENT surgery]. Anesteziologiia i reanimatologiia 20020101
[Use of transamine during general anesthesia in facial dermabrasion]. Anesteziologiia i reanimatologiia 20020101
Monoamine oxidase inhibitors: a new generation. Psychopharmacology bulletin 20020101
Region-dependent effects of acute and chronic tranylcypromine in vivo on [3H]2-BFI binding to brain imidazoline I(2) sites. European journal of pharmacology 20011005
Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test. Life sciences 20010907
Antidepressants in social anxiety disorder. Arquivos de neuro-psiquiatria 20010901
Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Drug metabolism and disposition: the biological fate of chemicals 20010601
High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy: III. Validation of a direct injection/on-line guard cartridge extraction-tandem mass spectrometry method for CYP2C19 inhibition evaluation. Journal of pharmaceutical and biomedical analysis 20010601
Assessment of DNA damage in C6 glioma cells after antidepressant treatment using an alkaline comet assay. Archives of toxicology 20010601
Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines. European journal of medicinal chemistry 20010601
Mechanisms of relaxation induced by angiotensin II in isolated canine and human uterine arteries. Journal of cardiovascular pharmacology 20010501
[A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science 20010501
Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behavioural brain research 20010408
In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene. Drug metabolism and disposition: the biological fate of chemicals 20010301
Role of ETB and B2 receptors in the ex vivo platelet inhibitory properties of endothelin and bradykinin in the mouse. British journal of pharmacology 20010201
Regulation of GFRalpha-1 and GFRalpha-2 mRNAs in rat brain by electroconvulsive seizure. Synapse (New York, N.Y.) 20010101
A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry. Drug metabolism and disposition: the biological fate of chemicals 20010101
Ping-pong gaze in combined intoxication with tranylcypromine, thioridazine, and clomipramine. Neuropsychiatry, neuropsychology, and behavioral neurology 20010101
Mimicking gene defects to treat drug dependence. Annals of the New York Academy of Sciences 20000101
Stroke resulting from a rapid switch from phenelzine to tranylcypromine. The Journal of clinical psychiatry 19980701
Experience with tranylcypromine in early Parkinson's disease. Journal of neural transmission. Supplementum 19980101
[Mianserin-induced hypertension 2 weeks after discontinuation of tranylcypromine]. Der Nervenarzt 19970701
Serotonin syndrome from venlafaxine-tranylcypromine interaction. Veterinary and human toxicology 19961001
Successful treatment of serotonin syndrome with chlorpromazine. The Medical journal of Australia 19960916
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. The Journal of neuroscience : the official journal of the Society for Neuroscience 19960401
Venlafaxine. Nursing 19960301
Chronic antidepressant treatment down-regulates the induction of c-fos mRNA in response to acute stress in rat frontal cortex. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 19950501
Fluoxetine and the serotonin syndrome. Annals of emergency medicine 19941101
[A case of tranylcypromine-induced hallucination]. Psychiatrische Praxis 19930501
[Intracranial hemorrhage following use of MAO inhibitor tranylcypromine and beer]. Nederlands tijdschrift voor geneeskunde 19930501
Tranylcypromine withdrawal phenomena. Journal of psychiatry & neuroscience : JPN 19930101
Abuse of monoamine oxidase inhibitors. The American journal of drug and alcohol abuse 19920101
Capgras syndrome in association with lithium toxicity. The British journal of psychiatry : the journal of mental science 19911201
Disseminated intravascular coagulation and acute myoglobinuric renal failure: a consequence of the serotonergic syndrome. Journal of clinical psychopharmacology 19910801
Interaction of butorphanol, with monoamine oxidase inhibitor, tranylcypromine. Forensic science international 19910301
Symptoms of major depression: acute effect of withdrawing antidepressants. Acta psychiatrica Scandinavica 19910301
Treatment of panic disorder and benzodiazepine withdrawal with valproate. The Journal of neuropsychiatry and clinical neurosciences 19910101
[The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine]. Farmakologiia i toksikologiia 19910101
Monosodium glutamate and tranylcypromine administration in healthy subjects. The Journal of clinical psychiatry 19900701
Adverse consequences of fluoxetine-MAOI combination therapy. The Journal of clinical psychiatry 19900601
Afternoon fatigue and somnolence associated with tranylcypromine treatment. The Journal of clinical psychiatry 19900501
Hypertensive crisis precipitated by a monoamine oxidase inhibitor in a patient with phaeochromocytoma. BMJ (Clinical research ed.) 19900303
Hypertensive episodes with tranylcypromine treatment. Journal of clinical psychopharmacology 19890601
Hypertensive crisis and broad complex bradycardia after a single dose of monoamine oxidase inhibitor. BMJ (Clinical research ed.) 19890408
Autoinduction of hypertensive reactions by tranylcypromine? Journal of clinical psychopharmacology 19890201
Common side effects associated with monoamine oxidase inhibitors. Progress in neuro-psychopharmacology & biological psychiatry 19890101
Severe daytime somnolence in patients treated with an MAOI. The American journal of psychiatry 19881201
Buspirone-induced hypomania: a case report. Journal of clinical psychopharmacology 19880601
Cardiac myonecrosis and monoamine oxidase inhibitor therapy. The American journal of medicine 19871001
Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat. Neuropharmacology 19870901
Fatal disseminated intravascular coagulation following a monoamine oxidase inhibitor/tricyclic interaction. Anaesthesia 19870701
Treatment of MAOI hypertensive crisis with sublingual nifedipine. The Journal of clinical psychiatry 19870601
Hypertension during anaesthesia with monoamine oxidase inhibitors. Anaesthesia 19870601
Cardiac myonecrosis in hypertensive crisis associated with monoamine oxidase inhibitor therapy. The American journal of medicine 19870501
Yohimbine- and tranylcypromine-induced postural hypotension. The American journal of psychiatry 19870101
Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor. The American journal of psychiatry 19851201
Successful treatment of a monoamine oxidase inhibitor-tyramine hypertensive emergency with intravenous labetalol. The New England journal of medicine 19850704
Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan. The American journal of psychiatry 19850401
Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management. Journal of clinical psychopharmacology 19850201
Brain monoamine oxidase in suckling rabbits treated with organophosphorus compound. I. Acute intoxication. Acta physiologica Polonica 19840101
The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. A controlled trial. Archives of general psychiatry 19830601
Does prostacyclin mediate alpha-adrenergic induced hypotension? Documenta ophthalmologica. Advances in ophthalmology 19820930
Reversal by bethanechol of sexual dysfunction caused by anticholinergic antidepressants. The American journal of psychiatry 19820901
Hypertensive crisis resulting from avocados and a MAO inhibitor. Drug intelligence & clinical pharmacy 19811101
Atrial flutter/fibrillation associated with tranylcypromine treatment. Journal of clinical psychopharmacology 19811101
Effect of caroxazone, a new antidepressant drug, on monoamine oxidases in healthy volunteers. British journal of clinical pharmacology 19810501
Alteration of lidocaine- or procaine-induced convulsions by manipulation of brain amines. Journal of dental research 19810201
Reduction of ECS-induced retrograde amnesia of passive avoidance conditioning after 5,7-dihydroxytryptamine median raphe nucleus lesion in the rat. Neuropsychobiology 19810101
Linoleic acid in the treatment of lithium toxicity and familial tremor. Prostaglandins and medicine 19800401
Hoarseness and aphonia as a side effect of tricyclic antidepressants. The American journal of psychiatry 19791201
Tranylcypromine induced hypertension is not mediated by the inhibition of prostacyclin synthesis. Prostaglandins and medicine 19791001
Degraded protein-containing food and monoamine oxidase inhibitors. The American journal of psychiatry 19771201
Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation. British journal of pharmacology 19770201
The tranylcypromine isomers: a controlled clinical trial. The American journal of psychiatry 19740901
Letter: Side effect of tranylcypromine. British medical journal 19740831
Tricyclic antidepressants and monoamine oxidase inhibitors. Archives of general psychiatry 19710601
Severe hyperpyrexia due to tranylcypromine-amphetamine toxicity. Annals of internal medicine 19690301
Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats. Proceedings of the Western Pharmacology Society 19660101

© 2019 Angene International Limited. All rights Reserved.